Clear All
12611 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00173-0915-61 00173-0915 Niraparib ZEJULA 300.0 mg/1 Chemotherapy Enzyme Inhibitor PARP Oral Jun 27, 2023 In Use
72237-0102-07 72237-0102 selinexor XPOVIO 40.0 mg/1 Chemotherapy Enzyme Inhibitor XPO1 Oral May 19, 2021 In Use
72237-0101-02 72237-0101 Selinexor XPOVIO 20.0 mg/1 Chemotherapy Enzyme Inhibitor XPO1 Oral Jul 10, 2019 In Use
00078-0567-61 00078-0567 Everolimus Afinitor 10.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Mar 22, 2010 In Use
72611-0785-02 72611-0785 Temsirolimus Injection Temsirolimus Chemotherapy Enzyme Inhibitor mTOR Intravenous May 8, 2020 In Use
71779-0125-01 71779-0125 duvelisib Copiktra 25.0 mg/1 Chemotherapy Enzyme Inhibitor PI3K Oral Sep 25, 2018 In Use
49884-0128-91 49884-0128 Everolimus Everolimus 10.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Nov 29, 2022 In Use
50881-0033-08 50881-0033 ruxolitinib JAKAFI XR 33.0 mg/1 Chemotherapy Enzyme Inhibitor JAK 1/2 Oral May 1, 2026 In Use
00173-0847-61 00173-0847 Dabrafenib Tafinlar 75.0 mg/1 Chemotherapy Enzyme Inhibitor BRAF Oral Jun 10, 2013 Dec 11, 2014 No Longer Used
00069-0757-30 00069-0757 Talazoparib Talzenna 1.0 mg/1 Chemotherapy Enzyme Inhibitor PARP Oral Apr 17, 2024 In Use
00378-3098-85 00378-3098 Everolimus Everolimus 7.5 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Dec 15, 2022 Feb 28, 2025 No Longer Used
70377-0011-23 70377-0011 Everolimus EVEROLIMUS 5.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral May 17, 2024 In Use
82249-0611-30 82249-0611 Everolimus Yulithira 5.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Jun 11, 2026 In Use
00245-0823-04 00245-0823 Everolimus TORPENZ 5.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Oct 21, 2025 In Use
82249-0612-30 82249-0612 Everolimus Yulithira 7.5 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Jun 11, 2026 In Use
00074-0576-34 00074-0576 Venetoclax Venclexta 100.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Nov 21, 2018 In Use
51991-0991-28 51991-0991 Everolimus Everolimus 3.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Jan 28, 2025 In Use
50242-0210-86 50242-0210 Pralsetinib Gavreto 100.0 mg/1 Chemotherapy Enzyme Inhibitor RET, DDR1, TRKC, FLT3, JAK1/2, TRKA, VEGFR2, PDGFRB, FGFR1 Oral Sep 15, 2020 Feb 11, 2022 In Use
72579-0017-01 72579-0017 Sonrotoclax BEQALZI 5.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Aug 31, 2026 In Use
72579-0020-01 72579-0020 Sonrotoclax BEQALZI 1.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Aug 31, 2026 In Use
00078-0627-51 00078-0627 Everolimus Afinitor 3.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Aug 29, 2012 In Use
60219-2279-02 60219-2279 Everolimus EVEROLIMUS 2.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Jan 14, 2025 In Use
72579-0022-01 72579-0022 Sonrotoclax BEQALZI 80.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Aug 31, 2026 In Use
72579-0022-08 72579-0022 Sonrotoclax BEQALZI 80.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Aug 31, 2026 In Use
72579-0025-02 72579-0025 Sonrotoclax BEQALZI 20.0 mg/1 Chemotherapy Enzyme Inhibitor BCL-2 Oral Aug 31, 2026 In Use

Found 12611 results — Export these results